The head of the American pharmaceutical concern Pfizer Albert Bourla has no good news. As he said in an interview with the French television station BFM TV, "the coronavirus will continue to circulate for many years to come." What will happen next with the epidemic restrictions?
A new variant of the coronavirus called Omikron is raging around the world. Its detection has caused considerable concern as it is causing a surge in infections.
Albert Bourla, the CEO of the pharmaceutical concern, referred to the current situation. According to him, "the coronavirus will circulate for many years to come." He added that "it's a virus that has spread all over the world, so it's very hard to get rid of."
- The wave related to the Omikron variant should be the last one with numerous limitations, Bourla told French television station BFM TV. In his opinion, there will not be many restrictions in the future as vaccines and treatments have been successful.
The vaccine is "safe and effective"
According to the CEO of Pfizer, the preparation against COVID-19 for children is "safe and effective". However, he noted that the fourth dose of the vaccine should not yet be approved for use in everyone due to insufficient data.
As part of the fight against the pandemic, Pfizer is preparing an investment plan in France worth EUR 520 million, Bourla said. Additionally, a collaboration was established with the French group Novasep to develop a drug against COVID-19.
Probe